three new ORAL drugs for multiple sclerosis...Ampyra, cladribine, and fingolimod
March 2010
Please see updated information from the FDA concerning Ampyra and the risk of seizures
These will be the first oral drugs approved for treating MS.
Ampyra (Am-PEER-ah, dalfampridine) will be available soon through specialty pharmacies...and costs over $13,000 a year.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote